Thanks so much for posting this article. I think it's really relevant to a lot of the discussions we're having. Couple thoughts.
1. "During the videoconference, Morganroth argued that offering Botox in a pandemic wasn’t so different from a grocery store allowing customers to buy candy alongside staples."
This here encompasses the essence of this. Yes, it's effectively no different to the customer. Medicine, though, is by definition focused primarily on the health of patients foremost and that is grounded in our licensing/training. We must retain the elements of free-market (transparency of costs), but maintain our ethical standards.
2. "Today, when an investment firm buys a doctor’s office, what it’s actually buying are the office’s “nonclinical” assets. In theory, physicians control all medical decisions and agree to pay a management fee to a newly created company, which handles administrative tasks such as billing and marketing.In practice, though, investors expect some influence over medical decision-making, which, after all, is connected to profits."
This is a great point. PE knows there's a bloat in medicine and thinks by bringing in technology/automation, they can cut costs, but really they end up creating incentives for doctors that don't align with patient care (billing). They turn a profit, but don't help patients.